IVMT-RX-3

N/A

Report date: 2025/05/22 17:22:48
NME

Base Information

Drug NameIVMT-RX-3
Drug Alias NameIVMT-RX-3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSyndecan binding protein (Syntenin), isoform CRA_c inhibitors
TargetsSyndecan binding protein (Syntenin), isoform CRA_c
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVirginia Commonwealth University
China Registration ClassN/A

Develop Information

Active CompaniesVirginia Commonwealth University
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A